About this trial
To evaluate whether routine ureterolysis during Total Laparoscopic Hysterectomy for benign gynecologic conditions affects operative efficiency and perioperative safety compared with a selective ureterolysis approach.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Previous pelvic radiation
Known ureteric abnormalities or pathology
Severe cardiopulmonary disease precluding laparoscopy
Inability to provide informed consent
Trial design
Parallel
Treatments tested in this trial
Routine Ureterolysis
Procedure/Surgeryfor all cases of the group: After entering the pelvis and before uterine vessel ligation, routine bilateral ureterolysis will be performed. The retroperitoneal space will be opened by incising the peritoneum overlying the ureter, followed by careful blunt and sharp dissection to identify each ureter and trace its course from the pelvic brim toward the uterine artery and ureteric tunnel. Surrounding tissue will be dissected only to the extent necessary to obtain clear visualization and safe lateralization of the ureter before completing the hysterectomy. Excessive skeletonization, thermal spread, and disruption of the ureteral blood supply will be avoided. The procedure will be performed using a standardized technique and documented in the operative record.
Selective Ureterolysis
Procedure/Surgeryfor selected cases of the group: After entering the pelvis and before uterine vessel ligation, routine bilateral ureterolysis will be performed. The retroperitoneal space will be opened by incising the peritoneum overlying the ureter, followed by careful blunt and sharp dissection to identify each ureter and trace its course from the pelvic brim toward the uterine artery and ureteric tunnel. Surrounding tissue will be dissected only to the extent necessary to obtain clear visualization and safe lateralization of the ureter before completing the hysterectomy. Excessive skeletonization, thermal spread, and disruption of the ureteral blood supply will be avoided. The procedure will be performed using a standardized technique and documented in the operative record.
Treatment groups
Trial outcomes
Primary outcomes
Total operative duration
Total operative duration in minutes measured from skin incision to skin closure
Secondary outcomes
time needed for ureterolysis
Determine time needed for ureterolysis during TLH
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
ClinAmygate
Lead sponsor
Cairo University
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: